Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, June 2008, p. 2253-2255, Vol. 52, No. 6
0066-4804/08/$08.00+0 doi:10.1128/AAC.01536-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina 27599-7435
Received 28 November 2007/ Returned for modification 20 January 2008/ Accepted 11 March 2008
Pafuramidine is a novel orally active antimalarial. To identify a combination partner, we measured the in vitro antimalarial activities of the active metabolite, DB75, with amodiaquine, artemisinin, atovaquone, azithromycin, chloroquine, clindamycin, mefloquine, piperaquine, pyronaridine, tafenoquine, and tetracycline. None of the drugs tested demonstrated antagonistic or synergistic activity in combination with pafuramidine.
Published ahead of print on 24 March 2008.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»